The Helix Award presented annually by bionorthTX has been renamed the Dr. Dennis K. Stone Life Science Achievement Award in honor of Dr. Stone’s decades of service to the North Texas health care and life sciences community. The award recognizes individuals for their achievements as innovators, leaders, mentors and educators in the health care and life sciences industry.
Dr. Stone began his medical career as Professor of Internal Medicine, Physiology and Biochemistry at UT Southwestern. In 1998, the Medical Center established the Office of Technology Development and named him as Vice President. There he directed licensing operations, biotechnology development and was the liaison with pharmaceutical and biotechnology companies interested in partnering with UT Southwestern scientists.
In 2002, Dr. Stone ensured UT Southwestern played an active role in the Dallas Plan’s Biotechnology Initiative, which brought together the City of Dallas, UT Southwestern and STARTech Early Ventures, a business accelerator, to help grow Dallas’s fledgling biotech industry. In 2009, he helped lay the groundwork for future biotech innovations in Dallas with the opening of the BioCenter, a biotech park within the Southwestern Medical District.
In August 2011, he became Chief Scientific Officer of Remeditex Ventures, which provides business and scientific discipline to translate promising scientific discovery into products and therapies for diseases with great need.
In October 2016, Dr. Stone was the recipient of the 2016 Helix Award at bionorthTX's annual iC3 summit. The award was presented to Dr. Stone’s family members, including his wife, Dr. Helen Hobbs, and their son, Dr. Langdon Stone, both at UT Southwestern. The presentation was made by Dr. Kern Wildenthal, President Emeritus of the Medical Center, and President of the Children’s Medical Center Foundation in Dallas. “This award could not have been given to a more appropriate person. Dennis’ contributions to medicine, science and the community will result in a legacy his family can be very proud of,” said Dr. Wildenthal.
“I can’t think of anyone who has done more to promote biomedical research, to promote the formation of companies, or to promote the North Texas biotech community than Dennis Stone…It is most appropriate for this award to be renamed in his honor,” said Warren Huff, CEO of Reata Pharmaceutical.
“All of us here in the Office of Technology Development at the UT Southwestern Medical Center owe Dr. Stone a debt of gratitude for his years of service…Perhaps most importantly the patient population in North Texas, the U.S. and the world benefitted from the commercialization, mass production, and wide distribution of the medicines, treatments and technologies at UT Southwestern enabled under his watch,” concluded Frank Grassler, VP of Technology Development at UT Southwestern.
To read more, please click here.